Table 13 Agreement between PET/CT and BMB in DLBCL cases
From: PET/CT and bone marrow biopsy (BMB) in evaluating bone marrow in lymphoma
| Â | Â | BMB | Â | Total | |
|---|---|---|---|---|---|
Negative | Positive | Â | |||
PET/CT | Negative | Count | 12 | 0 | 12 |
% of total | 44.4% | 0.0% | 44.4% | ||
Positive | Count | 7 | 8 | 15 | |
% of total | 25.9% | 29.6% | 55.6% | ||
Total | Â | Count | 19 | 8 | 27 |
% of total | 70.4% | 29.6% | 100.0% | ||